Nutex Health Inc. (NASDAQ:NUTX) Given Average Recommendation of "Buy" by Brokerages

Key Points

• Analysts maintain a bullish view: Nutex Health has a consensus “Buy” rating from five firms, with an average 12-month price target of $317.50. Recent target increases include B. Riley’s $325 target and Lake Street Capital’s $310 target.
• Institutional ownership has expanded: Several hedge funds and investment managers recently initiated or increased positions, though institutions collectively own just 5.32% of the company.
• Quarterly earnings exceeded expectations: Nutex Health reported $9.38 in quarterly EPS versus the $4.95 consensus estimate, while revenue came in at $210.75 million. Shares opened at $200.24, near the company’s 52-week high of $204.00.

Nutex Health Inc. (NASDAQ:NUTX - Get Free Report) has been given a consensus recommendation of "Buy" by the five research firms that are presently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation, three have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month target price among analysts that have covered the stock in the last year is $317.50.

Several equities analysts recently commented on the stock. B. Riley Financial increased their target price on shares of Nutex Health from $290.00 to $325.00 and gave the company a "buy" rating in a report on Friday, September 4th. B Riley reissued a "buy" rating on shares of Nutex Health in a research note on Friday, September 4th. Lake Street Capital restated a "buy" rating and set a $310.00 price target (up from $235.00) on shares of Nutex Health in a research report on Tuesday, August 11th. Zacks Research raised Nutex Health from a "hold" rating to a "strong-buy" rating in a research note on Monday, August 24th. Finally, Weiss Ratings upgraded Nutex Health from a "hold (c)" rating to a "hold (c+)" rating in a report on Tuesday, July 28th.

Institutional Trading of Nutex Health

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Quantinno Capital Management LP bought a new position in shares of Nutex Health in the first quarter worth approximately $843,000. First Trust Advisors LP raised its holdings in Nutex Health by 60.0% during the 1st quarter. First Trust Advisors LP now owns 18,335 shares of the company's stock valued at $1,743,000 after buying an additional 6,874 shares during the last quarter. Winmill & CO. Inc. purchased a new stake in Nutex Health during the 2nd quarter valued at $11,168,000. Corient Private Wealth LP purchased a new stake in Nutex Health during the 2nd quarter valued at $1,142,000. Finally, Empowered Funds LLC bought a new stake in Nutex Health in the 1st quarter worth $3,084,000. Institutional investors own 5.32% of the company's stock.

Nutex Health Price Performance

NUTX stock opened at $200.24 on Monday. The stock has a market cap of $1.37 billion, a PE ratio of 7.86 and a beta of 0.28. The company has a debt-to-equity ratio of 0.59, a current ratio of 5.00 and a quick ratio of 4.96. Nutex Health has a one year low of $83.99 and a one year high of $204.00. The firm has a 50 day simple moving average of $176.69 and a two-hundred day simple moving average of $140.29.

Nutex Health (NASDAQ:NUTX - Get Free Report) last released its quarterly earnings results on Thursday, August 6th. The company reported $9.38 earnings per share for the quarter, beating analysts' consensus estimates of $4.95 by $4.43. The business had revenue of $210.75 million for the quarter, compared to the consensus estimate of $215.03 million. Nutex Health had a return on equity of 39.74% and a net margin of 21.25%. On average, analysts predict that Nutex Health will post 27.58 EPS for the current fiscal year.

Nutex Health Company Profile

Nutex Health Inc NASDAQ: NUTX is a physician-led healthcare services company that operates an integrated network of hospitals, outpatient facilities and physician practices. The company focuses on delivering emergency, inpatient and outpatient care through community-based healthcare facilities, including micro-hospitals designed to provide essential hospital services in convenient local settings.

Its services may include emergency medicine, primary care, specialty care, diagnostic testing, imaging, laboratory services and other ancillary healthcare offerings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.